Quality of life of persons taking care of children with inherited metabolic disease
Authors:
J. Michalik 1; M. Valenta 1; T. Honzík 2,3; M. Magner 2; J. Zeman 2,3; M. Hůlková 2; P. Ješina 3
Authors place of work:
Ústav speciálně pedagogických studií, Pedagogická fakulta Univerzity Palackého, Olomouc
přednostka doc. PhDr. Eva Souralová, Ph. D.
1; Klinika dětského a dorostového lékařství 1. LF UK a VFN, Praha
přednosta prof. MUDr. J. Zeman, DrSc.
2; Ústav dědičných metabolických poruch 1. LF UK a VFN, Praha
přednosta prof. MUDr. V. Kožich, CSc.
3
Published in the journal:
Čes-slov Pediat 2012; 67 (6): 376-384.
Category:
Original Papers
Summary
Inherited metabolic diseases (IMD) represent a large heterogenic group of diseases which require a long-term care. Improved diagnostic and, especially, therapeutic possibilities prolong the life of patients with IMD. It raises the questions of quality of life, not only to the patients, but also to those who take care of them. The authors describe psycho-socio-economic aspects mapping the quality of life persons who take care of children with IMD encounter.
The study evaluated questionnaires obtained from parents of children with metabolic diseases in general and a specific group of parents with children suffering from mucopolysaccharidosis (MPS). All respondents experienced deteriorated psychic stability, socioeconomic indices and social life of their families. The evaluation of the observed aspects proved to be worse in the IMD group. On the other hand, the married couples did not differ from the unmarried partners in the area of divorce rate, in comparison with the situation in the Czech Republic. The care of children with IMD includes a specialized health care as well as a necessary social therapeutic support reflecting the quality of life of the child and the family which takes care of the child.
Key words:
quality of life, persons taking care of the patients, hereditary metabolic disease, mucopolysaccharidosis
Zdroje
1. Fernandes J, Saudubray JM, van den Berghe G, et al. Diagnostics. Inborn Metabolic Disease – Diagnosis and Treatment. 4th ed. Springer, 2006.
2. Honzík T, Tesařová M, Hansíková H, et al. Klinické příznaky a laboratorní data u 75 dětí s neonatální manifestací mitochondriálního onemocnění: Návrh diagnostických algoritmů. Čes-slov Pediat 2010; 65 (7–8): 422–431.
3. Ješina P, Magner M, Poupětová H, et al. Mukopolysacharidóza I – klinické projevy u 24 dětí z České republiky a Slovenska. Čes-slov Pediat 2011; 66 (4): 215–225.
4. Hatzmann J, Heymans HS, Ferreri-Carbonell A, et al. Hidden consequences of success in pediatrics: parental health-related quality of life – results from the Care Project. Pediatrics 2008 Nov; 122 (5): e1030–1038. Epub 2008 Oct 13.
5. Read CY. The demands of biochemical genetic disorders: a survey of mothers of children with mitochondrial disease or phenylketonuria. J Pediatr Nurs 2003 Jun; 18 (3): 181–186.
6. Kim KR, Lee E, Namkoong K. Caregiver’s burden and quality of life in mitochondrial disease. Pediatric Neurology 2010; 42 (4): 271–276.
7. Waisbren SE, Rones M, Read CY, et al. Brief report: Predictors of parenting stress among parents of children with biochemical genetic disorders. J Pediatr Psychol 2004 Oct; 29 (7): 565–570.
8. Hatzmann J, Valstar MJ, Bosch AM, et al. Predicting health-related quality of life of parents of children with inherited metabolic diseases. Acta Paediatr 2009 Jul; 98 (7): 1205–1210. Epub 2009 Apr 21.
9. Mareš J, a kol. Kvalita života u dětí a dospívajících I. Brno: MSD, 2006: 6. ISBN 80-86633-65-9.
10. Mareš J, a kol. Kvalita života u dětí a dospívajících II. Brno: MSD, 2007. ISBN 978-80-7392-008-1.
11. Mareš J, a kol. Kvalita života u dětí a dospívajících III. Brno: MSD, 2008. ISBN 978-80-7392-076-0.
12. Michalík J, Zeman J, a kol. Mukopolysacharidóza. Olomouc: Spo-lečnost pro MPS, 2010. ISBN 978-80-86417-11-0.
13. Ješina P, Zeman J. Mukopolysacharidózy. Pediatrie pro praxi 2011; 12 (5): 74–79.
14. Emerson E, McCulloch A, Graham H, et al. Socioeconomic circum-stances and risk of psychiatric disorders among parents of children with early cognitive delay. Am J Intellect Dev Disabil 2010 Jan; 115 (1): 30–42.
15. Hoedt AE, Maurice-Stam H, Boelen CC, et al. Parenting a child with phenyketonuria or galactosemia: implication for health-related quality of life. J Inherit Metab Dis 2011; 34 (2): 391–398.
16. Noorda G, Hermans-Peters M, Smeitink J, et al. Mitochondrial disease: Needs and problems of children, their parents and family. A Systematic review and pilot study into need for information of parents during diagnostic phase. J Inherit Metab Dis 2007; 30 (3): 333–340.
17. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics 2004 Nov; 114 (5): e541–547.
18. Otevřený dopis „Důstojnost rodinám se zdravotně postiženými dětmi“. Informace Národní rady osob se zdravotním postižením č. 14-2012 [cit. 10. 2. 2012]. Dostupné z http://www.nrzp.cz/aktualne/informace- predsedy-nrzp-cr/742-informace-c-14-2012-otevreny-dopis-.html.
19. Emerson E, Hatton C, Llewellyn G, et al. Socio-economic position, household composition, health status and indicators of the well-being of mothers of children with and without intellectual disabilities. J Intellect Disabil Res 2006 Dec; 50 (Pt 12): 862–873. Erratum in: J Intellect Disabil Res 2007 Feb; 51 (Pt 2): 172.
20. Možný I. Česká společnost. Nejdůležitější fakta o kvalitě našeho života. Praha: Portál, 2002. ISBN 80-7178-624-1.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2012 Číslo 6
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Quality of life and morbidity in children after repair of congenital diaphragmatic hernia
- Difficulties in prenatal diagnostics trisomy 20 and its mosaic
- Acute disseminated encephalomyelitis – case report
- Diagnostics and therapy of neurogenic bladder in children